Free Industry Report: Your Guide To Clinical Trials In Central and Eastern Europe

Industry Pages™ is an annual report produced by Palleos Healthcare for pharmaceutical industry experts. This is a single brief document, aiming to assist decision makers in their considerations to conduct clinical projects in Central and Eastern Europe.

The Industry Pages™ report will enable readers to understand the clinical research market in Central and Eastern Europe, along with the landscape, key players, and emerging trends in the region.

In 2023, the U.S. Food and Drug Administration (FDA) approved a notably high number of pharmaceuticals, which is almost twice as high as the number of approvals in 2022. Among 55 drugs approved in 2023, a substantial portion of these — 42 — can be attributed to clinical trials conducted within countries located in Central and Eastern Europe. This statistic underscores the strategic importance of these regions in the clinical trial landscape and their role in the pharmaceutical development that meets the strict standards of the FDA.

Download the Industry Pages™ take your clinical trials to the next level!